The Cas-Br-E and ts-Mo BA-1 murine leukemia viruses (MuLV) induce a spongiform neurodegenerative disease with different clinical manifestations, namely, either hind limb paralysis (Cas-Br-E) or tremors, spasticity, and hind limb weakness (ts-Mo Ba-l). We constructed the chimeric NEBA-1 MuLV by replacing the long terminal repeat of Cas-Br-E MuLV with that of ts-Mo BA-1 MuLV. In SWR/J or CFW/D mice, NEBA-1 MuLV induced an ataxic neurological disease characterized by clinical signs different from those induced by both parents. Although NEBA-1 MuLV did not induce lesions in novel brain areas, the spongiform lesions were more severe in deep cerebellar nuclei and in the spinal cord than those found in paralyzed mice inoculated with Cas-Br-E MuLV. By in situ hybridization, we found that the distribution of the spongiform lesions closely correlated with the distribution of the infected central nervous system cells. In the spinal cord, a close correlation was found between the number of infected cells and the severity of the spongiform degeneration. Sequencing of the substituted ts-BA-l MuLV fragment and comparison with homologous sequences of Cas-Br-E and Moloney MuLV showed differences mainly in the U3 tandem direct repeats. Our results show that a few modifications within the U3 long terminal repeat allow the virus to cause more severe lesions in some central nervous system regions and that the severity of the spongiform degeneration correlates with the level of viral replication.
Of the several isolated murine retroviruses, a few have been shown to induce neurological diseases. Most of them cause a specific type of lesion in the central nervous system (CNS) characterized as a spongiform degeneration (15, 16) . The Cas-Br-E wild mouse ecotropic murine leukemia virus (MuLV) has been shown to cause a progressive form of hind limb paralysis after inoculation into newborn mice (30) . The spongiform myeloencephalopathy associated with this disease was observed mainly in the brainstem and in the anterior horns of the lumbosacral region of the spinal cord (1, 17, 31, 32) . We have shown that the primary determinant of the spongiform degeneration maps within the env gp7O region of the viral genome (8, 33) . We have also found that an additional determinant, influencing the incidence of the disease and its clinical manifestation, maps within the long terminal repeat (LTR) region of the genome (11) . This determinant is apparently responsible for the localization of the lesions within the CNS.
Another retrovirus, ts-Mo BA-1 (ts-BA-1) MuLV, identified as a temperature sensitive (ts) mutant of Moloney MuLV, has been reported to induce a neurological disease phenotypically different from that induced by Cas-Br-E MuLV and manifested by tremors, spasticity, and hind limb weakness. The spongiform lesions were observed mainly in the cerebellar grey matter, the brainstem, and the upper spinal cord (2) .
To determine whether the distinct localization of the CNS spongiform changes and the phenotypically different disease RETROVIRUS-INDUCED SPONGIFORM MYELOENCEPHALOPATHY viral DNA from Cas-Br-E MuLV was described previously (23) . Recombinant chimeric DNA was constructed as described previously (8, 11) .
Transfection procedure. Recombinant plasmid viral DNA was transfected by the calcium phosphate procedure (18) on NIH 3T3 cells. Viruses were recovered from the supernatant 5 to 10 days later, and titers were determined by the XC assay (37) and by the endpoint dilution and reverse transcriptase assay as previously described (23) . Titers of CasBr-E and NEBA-1 MuLVs were obtained on NIH 3T3 cells and were 6 x 105 to 2 x 106 PFU/ml for Cas-Br-E (pNE-8)
MuLV and 8 x 106 PFU/ml for NEBA-1 MuLV. The virus suspension was filtered through a HAWP nitrocellulose filter (pore size, 0.45 mm; Millipore Corp., Bedford, Mass.) before inoculation.
Hybridization procedures. Hirt supernatant DNA or cellular DNA were isolated as described previously (23) . They were analyzed by restriction endonuclease analysis followed by hybridization of Southern blots (42) with 32P-labeled probes as described previously (23) . Probes were the CasBr-E MuLV-specific TaqI-BamHI 1.05 kilobase-pair (kbp) env fragment previously described (35) and the Moloney U3 LTR consisting of a 0.3-kbp PstI-SacI fragment from a mutated Moloney MuLV LTR (39) . Probes were labeled by the random hexanucleotide primer extension method (13) .
Sequencing. The sequence of the ts-BA-1 LTR region was determined by the dideoxynucleotide method of Sanger et al. (38) by using double-stranded supercoiled plasmid DNA and Sequenase (United States Biochemicals). Oligonucleotide primers were complementary to the pUC 18 vector and to the viral sequence. Both strands of the genome were sequenced.
Pathology. Mice were anesthesized and perfused with 4% phosphate-buffered formaldehyde solution through the left heart. Brain and spinal cord sections were prepared as previously described (11) . The quantitative analysis of spongiform lesions and neuronal loss was done blind.
Quantitation of numbers of neurons and area determination were performed on anterior and intermediate horns of the spinal cord up to a line drawn between the dorsal tip of the central canal laterally to the grey-white matter junction. Numbers of neurons were determined by projecting a camera lucida image of the field to be examined onto a piece of tracing paper and indicating the position of each neuron by a dot. The area was determined by tracing the projected camera lucida image on a Zeiss MOP3.
In situ hybridization. Molecular hybridization of paraffinembedded tissues was done essentially as described previously (20) , using a 35S-labeled Cas-Br-E MuLV-specific env RNA probe. This probe was prepared with SP6 polymerase and 80,uCi of [a-35S]UTP (1, 000 Ci/mmol; Amersham Corp.) on an EcoRI-linearized DNA template, essentially as described previously (29) . The DNA used was from a plasmid constructed by ligating the Cas-Br-E MuLV-specific TaqIBamHI 1.05-kbp env fragment (35) flanked by polylinker sites into the EcoRI-HindIlI-cleaved SP64 or GEM-3 vector.
Sections were hybridized in the presence of 4 x 105 to 6 x 105 cpm of "S-labeled probe. After development of the radioautographic reaction, sections were counterstained with hematoxylin and eosin or hematoxylin alone.
For determination of numbers of infected cells in various CNS regions (see Table 3 ), sections were analyzed from two diseased mice inoculated with NEBA-1 MuLV (killed between 35 and 56 days postinoculation) and from four diseased mice inoculated with Cas-Br-E MuLV (killed at 105 days postinoculation). The mice were from the groups used for previous pathologic studies. Positive (Fig. 1B) .
To obtain infectious chimeric viruses, pNEBA-1 DNA was transfected onto NIH 3T3 cells, and infectious viruses were recovered from the culture supernatant 5 to 10 days later. Titers were determined on NIH 3T3 cells by an XC assay (37 (Fig. 2A) . With the env probe, the characteristic 1,065-and 940-bp XbaI fragments from the env region of Cas-Br-E MuLV DNA were detected (Fig. 2B ). DNAs extracted from the spleens of diseased mice were also digested with the same enzymes and hybridized with the same probes. Fragments identical to the ones observed in the unintegrated viral DNA were readily detected (Fig. 2) .
Together, these results indicated that the genome of the virus recovered after transfection of pNEBA-1 DNA and after in vivo replication had the expected structure of the chimeric molecule that was constructed and transfected and had not been grossly rearranged during its passage in NIH 3T3 cells nor in animals.
Clinical manifestations of the neurological disease induced by chimeric NEBA-1 MuLV. The chimeric NEBA-1 MuLV was inoculated intraperitoneally into newborn inbred SWR/J and outbred CFW/D mice. Both mouse strains have previously been shown to be susceptible to the parental neurotropic Cas-Br-E MuLV (8, 11 ; unpublished data). All mice inoculated with NEBA-1 MuLV developed a severe progressive neurological disease, which was lethal to all animals ( Fig. 3 ). This chimeric NEBA-1 MuLV appeared to induce disease with a shorter latent period than Cas-Br-E MuLV in SWR/J mice but not in CFW/D mice. In most mice, this disease was phenotypically different from the disease induced by the parental Cas-Br-E MuLV, particularly in the SWR/J mouse strain. The onset was characterized by a generalized tremulousness, spasticity of the tail, and extension reflex of the hind legs when the animal was lifted by the tail. This contrasted with the abduction reflex generally seen in diseased mice inoculated with Cas-Br-E MuLV. As the disease progressed, the head and body tremors and spasticity became more pronounced. The head tremors were constant and aggravated by normal motor activities. A progressive ataxia also developed: mice often lay on their side, unable to get on their feet unless helped to do so. The hind limbs showed proximal paraparesis, but most mice did not become totally paraplegic and hyperextended, as they did with Cas-Br-E MuLV. Virus titers measured in serum of two CFW/D mice inoculated with Cas-Br-E MuLV were 1 x 103 and 7.4 x 103 PFU/ml, while they were 6 x 104, 1.7 x 106, and 1.4 x 106 PFU/ml in three CFW/D mice inoculated with NEBA-1 MuLV, suggesting a much better replication of the chimeric MuLV in vivo.
These results indicated that NEBA-1 MuLV had the potential to induce a form of neurological disease phenotypically different from the one induced by Cas-Br-E MuLV. The 3' end of env pl5E and the U3 LTR region, which distinguish these two retroviruses, are responsible for this novel phenotype.
CNS pathology of NEBA-1 MuLV-induced disease. Since chimeric NEBA-1 and Cas-Br-E (pBR-NE-8) MuLVs induced neurodegenerative disorders with different clinical manifestations, the CNS distribution of the lesions in mice with each clinical form of the disease was studied. As reported for both parental Cas-Br-E (pBR-NE-8) and ts-BA-1 MuLVs, the chimeric NEBA-1 MuLV also induced a spongiform myeloencephalopathy without inflammation. The myelopathy consisted of a severe loss of motor neurons and gliosis within anterior and intermediate horns, gradually tapering off in the posterior horns, and not involving any J. VIROL. 106 (Cas-Br-E) or 8 x 106 (NEBA-1) PFU/ml. Animals were killed when they showed signs of advanced disease. The SWR/J mice injected with Cas-Br-E MuLV belonged to a group which had been studied previously (11) . inflammatory reaction (Table 1 and Fig. 4 ). Vacuoles were more numerous within anterior horns and at the junction between ventral grey and white matter where myelin staining was pale, particularly in anterior columns. Compared with Cas-Br-E (pBR-NE-8) MuLV, the chimeric NEBA-1 MuLV did not induce lesions in novel brain areas, and both viruses induced lesions in the midbrain (substantia nigra, red nucleus, tegmentum, and tectum), pons, medulla, and spinal cord. However, in NEBA-1 MuLV-inoculated mice, the spongiform changes in the deep cerebellar nuclei and spinal cord ( Table 2 and Fig. 4 ) and the neuronal loss in the spinal cord (Table 1 ) appeared to be more severe than those seen with Cas-Br-E MuLV. As expected, outbred CFW/D mice showed fewer differences between groups of mice inoculated by both viruses and more individual variations than inbred SWR/J mice in this analysis. The myeloencephalopathy caused by the parental CasBr-E MuLV involves abundant gliosis. The extent of gliosis observed in Cas-Br-E and NEBA-1 MuLV-infected animals was assessed by using an antiserum directed against GFAP, which is an astrocyte-specific marker. This antiserum strongly stains reactive astrocytes, while normal fibrillary astrocytes display weaker immunoreactivity. Gliosis predominated in areas of spongiform lesions and tapered off gradually in adjacent nonvacuolated regions. In the two regions of the CNS (deep cerebellar region and spinal cord) which clearly demonstrated distinct levels of spongiform changes in mice inoculated with Cas-Br-E or NEBA-1 MuLV, the extent of gliosis observed mirrored (although not perfectly) the extent of spongiform changes, being more pronounced in mice inoculated with NEBA-1 MuLV (Fig.  5) . The severe spinal spongiform lesions did not correlate with the clinical manifestations of the disease, since the NEBA-1 MuLV-inoculated mice showed no signs of fore limb paralysis and a moderate hind limb paralysis. However, the severity of the CNS lesions in the deep cerebellar nuclei correlated well with the signs of ataxia observed.
Detection of viral RNA in affected CNS areas by in situ hybridization. The marked CNS spongiform lesions seen with NEBA-1 MuLV may have resulted from a higher replication rate of the virus in the CNS. To study the extent of virus replication and to identify the target cells in which virus replication occurred, we used in situ hybridization with a probe specific to the env region of Cas-Br-E MuLV, also shared by NEBA-1 MuLV. This probe was selected because it does not hybridize to mouse endogenous viral sequences (35) and therefore allows the detection of sequences from the inoculated virus only. With this technique, infected cells were detected in all regions affected by the spongiform degeneration. Furthermore, there was a good correspondence between areas which harbored the higher levels of spongiform changes and gliosis and the location of infected cells (Fig. 5) . In the spinal cord, where more pronounced spongiform degeneration, gliosis, and neuronal loss were observed in animals injected with NEBA-1 MuLV than in those injected with Cas-Br-E MuLV, significantly more infected cells were detected in diseased mice inoculated with NEBA-1 MuLV (Table 3 and Fig. 5 ). In the deep cerebellar nuclei and brainstems of CFW/D mice inoculated with NEBA-1 or Cas-Br-E MuLV, spongiform lesions were more or less comparable, and the number of cells in which viral RNA was detected was not significantly different ( , and infected cells were identified by in situ hybridization with a "S-labeled virus-specific probe (C and F). In the NEBA-1-infected animal, both the extent of gliosis (A and B) and the number of infected cells (C) were greater than that observed for Cas-Br-E MuLV (D through F). With both viruses, gliosis and the number of infected cells were most prominent in anterior and intermediate regions, while posterior horns were largely spared. Note also the more extensive spongiform degeneration in the NEBA-1 MuLV-infected mouse. Sections were counterstained with Harris hematoxylin. In situ hybridization was visualized by dark-field microscopy. Bars, 100 ,um (A, C, D, and F) or 50 pum (B and E).
MuLV did not appear to differ from those infected with Cas-Br-E MuLV; these data will be presented separately (D. Kay, Y. Robitaille, and P. Jolicoeur, unpublished data). Together, these results showed that the distribution and severity of spongiform degeneration closely correlated with the location and number of infected cells.
Sequencing the U3 LTR region of ts-BA-1 MuLV. Since NEBA-1 MuLV induces a neurological disease with different clinical signs and after a shorter latency than Cas-Br-E MuLV and since the genomes of both viruses differ only by their C-terminal env piSE and U3 LTR, it was of interest to obtain the nucleotide sequence of this region of ts-BA-1 MuLV in order to compare it with homologous sequences of Cas-Br-E and Moloney MuLVs (Fig. 6 ). Between the ClaI J. VIROL. site and the end of the LTR, the ts-BA-1 MuLV sequence differed from the Moloney MuLV sequence by only one point mutation (nucleotide 92), and this mutation did not result in a substitution of the amino acid residue. There were 18 nucleotide changes in the U3 region, 11 of which were localized within the 85-bp direct repeat enhancer sequences, 2 of which were in the R region, and 6 of which were in the U5 region.
Comparison of the ts-BA-1 MuLV sequence with that of Cas-Br-E MuLV revealed more differences. Between the ClaI site and the LTR, there are 12 nucleotide differences, 11 of which are localized in the coding region of pi5E (TM). However, the amino acid sequence coded by this region is identical in both MuLVs. In the U3 region, the most notable difference is the presence of only one copy of the two direct repeats in Cas-Br-E MuLV DNA, compared with two copies found in ts-BA-1 or Moloney MuLVs; there are also 45 additional nucleotide differences in this U3 region, 2 in the R, and 6 in the U5.
Therefore, the differences observed in the region between the ClaI and the R LTR region of ts-BA-1 MuLV allows this virus to replicate much more efficiently in some areas of the A.-. 360  370  380  390  400  410  420  430  440   450  460  470 ts-BA-1 CAGGATGTCTGTGGTAAGCCGTTCCTGCCCCGGCTCAGGGCCAGGAACAGATGGTCCCCAGATGCGGTCCAGCCCTCAGCAGTTTCTAGTGAATCATCAGATGTTTCCAGGGTGCCCCAA and tremulousness and which caused spongiform lesions in the cerebral cortex (11) . This NEBA-1 MuLV-induced disease is mainly characterized by head and body tremors, ataxia, and hind limb weakness. The results obtained with this virus clearly showed that minor changes of a retrovirus within the U3 LTR, a noncoding region, can alter its disease-inducing potential. This emphasizes the need to search for common pathogens or pathogenesis in human diseases showing similar pathologies even when the topography of the lesions and their clinical manifestations are distinct.
Histological examination of the CNS spongiform lesions showed that their distribution in the brainstem, the spinal cord, and deep cerebellar regions was similar to that seen with Cas-Br-E MuLV. However, within the deep cerebellar region and the spinal cord, lesions were more extensive and severe than in corresponding regions of diseased mice inoculated with Cas-Br-E MuLV, especially in SWR/J mice. In CFW/D outbred mice, the more severe lesions caused by NEBA-1 MuLV were only apparent in the spinal cord. Surprisingly, and in contrast with the Cas-Br-E MuLVinduced disease, despite extensive lumbar cord involvement, complete paraplegia accompanied by total hind limb extension was not observed; instead, mice seemed to develop moderate paraparesis. The upper spinal cord lesions did not induce an observable forelimb paralysis either. We cannot explain this discrepancy in view of the extensive loss of lumbosacral motor neurons in both models and the severe destruction of the upper spinal cord motor neurons in NEBA-1 MuLV-inoculated mice. However, the more extensive cerebellar lesions seen in SWR/J mice are likely to be responsible for their novel ataxic syndrome. The cerebellar lesions might also have decreased the hind limb spasticity and made the hind limb paralysis less apparent.
The chimeric NEBA-1 MuLV seems to replicate in mice to higher levels than Cas-Br-E MuLV, as reflected by the viral titers obtained in the sera of a few CFW/D mice tested.
This virus also seems to replicate better than Cas-Br-E MuLV in some CNS regions, as estimated by in situ hybridization. We found that infected cells were more numerous in the spinal cords of mice inoculated with NEBA-1 MuLV than in those inoculated with Cas-Br-E MuLV. In this CNS area, NEBA-1 MuLV-inoculated mice had more severe spongiform lesions than Cas-Br-E MuLV-inoculated mice, suggesting that the appearance of spongiform lesions correlates with the levels of virus replication in affected areas. This correlation was also apparent for other CNS regions, namely, the deep cerebellar regions and the brainstems of CFW/D mice, which exhibited comparable numbers of infected cells and pathological changes with both viruses.
These results suggest that the development of spongiform lesions is dependent on the presence of high levels of viral mRNA and, presumably, high levels of viral proteins and viruses in susceptible areas. From our previous work, we postulate that one of these proteins must be the env gp70 protein shown to harbor the primary determinant of this spongiform degeneration (33) .
The The chimeric NEBA-1 MuLV differs from Cas-Br-E MuLV in its U3 LTR region and in a short region of the carboxy terminus of env pl5E. Therefore, this region, and this region alone, derived from ts-BA-1 MuLV, is responsible for its novel characteristics: higher viremia, preferential destruction of deep cerebellar nuclei and spinal cord, and higher replication in the spinal cord resulting in clinical signs of the disease different from those observed with the parental viruses. The most simple explanation for our present data is that the ts-BA-1 U3 LTR-carboxy-terminal env pl5E
region allows the NEBA-1 MuLV to replicate more efficiently in these areas than the corresponding sequences from
Cas-Br-E MuLV, thus leading to more severe spongiform lesions in a shorter time, at least in the spinal cord. Within this viral fragment, the U3 LTR sequences are most likely responsible for this effect. Indeed, the U3 tandem direct repeats of MuLV are known to function as enhancers (25, 26) and have previously been shown to determine the tissue (5, 10, 36) and disease (6, 7, 9, 44) (33) . Our present results reveal that the Cas-Br-E MuLV gp7O is a much more potent inducer of spongiform lesions than that of the ts-BA-1 MuLV, assuming that gp7O harbors the disease determinant in both viruses. Together, our data illustrate the presence of two distinct determinants on these viral genomes: one (gp7O) is responsible for the appearance of the spongiform degeneration; the second (the U3 LTR region) facilitates the preferential replication of the virus within specific CNS regions and in doing so determines the clinical presentation of the disease.
